US Company Agrees To Buy Appili

Halifax-based drug discovery company Appili Therapeutics has agreed to be acquired by Richmond, Virginia-based Aditxt for C$16.8 million in cash, stock and assumed debt, though the acquirer has to raise US$20 million to close the deal.
Last week, the two companies jointly announced the sale agreement, which is denominated in U.S. dollars and will pay Appili investors 4.7 US cents in cash plus